Last Updated on September 5, 2025 by The Health Master
Pregabalin and Tapentadol
Delhi’s Government of NCT has taken a proactive measure against a growing drug menace relative to addiction with respect to Pregabalin and Tapentadol.
The Drug Control Department (DCD) has issued a notice to all chemists in Delhi that they should not sell Pregabalin and Tapentadol without prescriptions.
This is an advisory to avoid addiction with a bunch of follow-up consequences.
What’s different about this announcement from the others?
No More OTC Sales of Abused Combinations
Let us know that casual consumers will no longer be able to pick up powerful drugs for their medicine cabinet without any guidance.
On August 14, 2025, a letter signed by Kamal Ranjan Chawla, Head of Office and Controlling Authority of the Drug Control Department, was sent to all chemists’ associations in Delhi; any Over-the-Counter (OTC) sale of the following formulations is thus advised:
- Pregabalin—often prescribed for neuropathic pain and seizures, but for many others, it’s a potential high.
- Tapentadol—a potent opioid analgesic for pain relief, but for countless others, it’s a way to get addicted.
These drugs should NEVER be dispensed without appropriate prescriptions because they are extremely addictive.
These drugs are usually dispensed under a doctor’s supervision, but in India, of late, they’re out of control.
The Significance Behind the Release
This announcement is merely the latest step in a confrontation status that the National Capital is experiencing with substance abuse.
Such levels of abuse have been so high that the All India Organization of Chemists and Druggists (AIOCD) approached the union home minister about both pregabalin and tapentadol abuse.
The latter can be found online anywhere and everywhere, making it an integral fight against both physical chemists and online organizations.
Moreover, this advisory serves as a reminder to chemists who may not be following existing drug laws relative to inventory as per the Drugs Rules, 1945, so this advisory informs that any firm or chemist found to be noncompliant will receive strict action.
This is not just a Delhi issue. This is everywhere else as well.
We’ve seen other states take measures against pregabalin and tapentadol. This is not an isolated, Delhi-only incident.
The misuse has become an all-India issue that deserves all-state action.
Therefore, the Delhi Drug Control Department’s latest report is a step in the positive direction, where public health is concerned.
Q: Why was this advisory issued?
A: To prevent misuse and the possibility of addiction by allowing pregabalin and tapentadol to be purchased without prescriptions when they would be sold by chemists.
Q: What will happen if chemists do not adhere to this advisory?
A: This advisory does warn that any firm or chemist found noncompliant to such newly discovered regulations will face strict legal action.
Disclaimer: This article contains information obtained from the source mentioned below. Our team made changes in the format to rewrite and present the news or article in a unique format.
Disclaimer: The information we have provided is for general knowledge and for informational purpose only and it cannot be treated as medical advice. Always consult your doctor for any health issues and / or for the treatment of the same. The Health Master does not claim responsibility for this information.
USFDA Inspection: At Zydus with Zero observations
Key Notes on Revised Schedule M: Plant and equipment
Drug recall: Alembic recalls 9,492 bottles of Doxepin Capsules
Focus on R&D, secure Patents for New Drugs: PM
Big Push for Safer Medicines: Launches “SHRESTH” to rank States
Drug recall: Sun Pharma recalls 11,328 bottles of BP drug
New Draft Standards for IVD Medical Devices: CDSCO
UCPMP 2024: A New Era for Ethical Pharma Marketing
Final Call: No more extensions for WHO-GMP certification
CDSCO Approval: Panel Nod For Alfuzosin-Tadalafil FDC PMS Study
